{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T11:51:18Z","timestamp":1781092278154,"version":"3.54.1"},"reference-count":94,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.resinv.2022.04.004","type":"journal-article","created":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T23:43:43Z","timestamp":1651448623000},"page":"531-542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Association of the RAGE\/RAGE-ligand axis with interstitial lung disease and its acute exacerbation"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9117-1934","authenticated-orcid":false,"given":"Kakuhiro","family":"Yamaguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4922-5334","authenticated-orcid":false,"given":"Hiroshi","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinjiro","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Horimasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Fujitaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noboru","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2022.04.004_bib1","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(11)60052-4","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"King","year":"2011","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.resinv.2022.04.004_bib2","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2022.04.004_bib3","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1164\/rccm.201403-0566OC","article-title":"Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences","volume":"190","author":"Natsuizaka","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2022.04.004_bib4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1164\/rccm.201604-0801CI","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report","volume":"194","author":"Collard","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2022.04.004_bib5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.rmed.2019.02.012","article-title":"Acute exacerbation of interstitial lung disease after procedures","volume":"150","author":"Amundson","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2022.04.004_bib6","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3389\/fmed.2017.00176","article-title":"Acute exacerbation in interstitial lung disease","volume":"4","author":"Leuschner","year":"2017","journal-title":"Front Med"},{"key":"10.1016\/j.resinv.2022.04.004_bib7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.resinv.2018.03.002","article-title":"Anticancer drug treatment for advanced lung cancer with interstitial lung disease","volume":"56","author":"Otsubo","year":"2018","journal-title":"Respiratory investigation"},{"key":"10.1016\/j.resinv.2022.04.004_bib8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1165\/rcmb.2003-0423OC","article-title":"Identification of genes differentially expressed in rat alveolar type I cells","volume":"31","author":"Dahlin","year":"2004","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.resinv.2022.04.004_bib9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00441-005-0069-0","article-title":"Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cells","volume":"323","author":"Demling","year":"2006","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.resinv.2022.04.004_bib10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2353\/ajpath.2008.070569","article-title":"A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis","volume":"172","author":"Englert","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.resinv.2022.04.004_bib11","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0092-8674(00)80801-6","article-title":"RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100\/calgranulin polypeptides","volume":"97","author":"Hofmann","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.resinv.2022.04.004_bib12","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jphs.2016.02.005","article-title":"Soluble form of the receptor for advanced glycation end-products attenuates inflammatory pathogenesis in a rat model of lipopolysaccharide-induced lung injury","volume":"130","author":"Izushi","year":"2016","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.resinv.2022.04.004_bib13","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/resp.12995","article-title":"AGER gene polymorphisms and soluble receptor for advanced glycation end product in patients with idiopathic pulmonary fibrosis","volume":"22","author":"Yamaguchi","year":"2017","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2022.04.004_bib14","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1513\/AnnalsATS.201606-485OC","article-title":"Plasma soluble receptor for advanced glycation end products in idiopathic pulmonary fibrosis","volume":"14","author":"Manichaikul","year":"2017","journal-title":"Annal Am Thoracic Soc"},{"key":"10.1016\/j.resinv.2022.04.004_bib15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12931-018-0924-7","article-title":"Serum AGE\/RAGEs as potential biomarker in idiopathic pulmonary fibrosis","volume":"19","author":"Machahua","year":"2018","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2022.04.004_bib16","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.athoracsur.2021.05.059","article-title":"Role of soluble receptor for advanced glycation end products in postoperative fibrotic lung injury","volume":"113","author":"Nakao","year":"2022","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.resinv.2022.04.004_bib17","doi-asserted-by":"crossref","first-page":"106131","DOI":"10.1016\/j.rmed.2020.106131","article-title":"Serum high-mobility group box 1 as a predictive marker for cytotoxic chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease","volume":"172","author":"Nakao","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2022.04.004_bib18","doi-asserted-by":"crossref","first-page":"917108","DOI":"10.1155\/2010\/917108","article-title":"The receptor for advanced glycation end products (RAGE) and the lung","volume":"2010","author":"Buckley","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.resinv.2022.04.004_bib19","doi-asserted-by":"crossref","first-page":"14998","DOI":"10.1016\/S0021-9258(18)42138-2","article-title":"Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins","volume":"267","author":"Neeper","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2022.04.004_bib20","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/01.HYP.0000234904.43861.f7","article-title":"C-Reactive protein upregulates receptor for advanced glycation end products expression in human endothelial cells","volume":"48","author":"Zhong","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.resinv.2022.04.004_bib21","doi-asserted-by":"crossref","first-page":"732450","DOI":"10.1155\/2015\/732450","article-title":"Advanced glycation end products enhance macrophages polarization into M1 phenotype through activating RAGE\/NF-\u03baB pathway","volume":"2015","author":"Jin","year":"2015","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.resinv.2022.04.004_bib22","doi-asserted-by":"crossref","first-page":"19919","DOI":"10.1074\/jbc.274.28.19919","article-title":"Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways","volume":"274","author":"Huttunen","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2022.04.004_bib23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2796.2003.01301.x","article-title":"Amphoterin as an extracellular regulator of cell motility: from discovery to disease","volume":"255","author":"Huttunen","year":"2004","journal-title":"J Intern Med"},{"key":"10.1016\/j.resinv.2022.04.004_bib24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ejps.2017.12.019","article-title":"Production and application of HMGB1 derived recombinant RAGE-antagonist peptide for anti-inflammatory therapy in acute lung injury","volume":"114","author":"Lee","year":"2018","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.resinv.2022.04.004_bib25","doi-asserted-by":"crossref","first-page":"7208","DOI":"10.1038\/s41598-017-07638-2","article-title":"RAGE inhibition reduces acute lung injury in mice","volume":"7","author":"Blondonnet","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2022.04.004_bib26","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1042\/bj20021371","article-title":"Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury","volume":"370","author":"Yonekura","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.resinv.2022.04.004_bib27","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/2012","article-title":"Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts","volume":"4","author":"Park","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.resinv.2022.04.004_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2007.07.025","article-title":"Receptor for advanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implications","volume":"196","author":"Basta","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.resinv.2022.04.004_bib29","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1124\/mol.52.1.54","article-title":"Recombinant advanced glycation end product receptor pharmacokinetics in normal and diabetic rats","volume":"52","author":"Renard","year":"1997","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.resinv.2022.04.004_bib30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/sj.gene.6363861","article-title":"RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response","volume":"3","author":"Hofmann","year":"2002","journal-title":"Gene Immun"},{"key":"10.1016\/j.resinv.2022.04.004_bib31","doi-asserted-by":"crossref","first-page":"5174","DOI":"10.1210\/jc.2009-1067","article-title":"Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels","volume":"94","author":"Gaens","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.resinv.2022.04.004_bib32","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1164\/rccm.201302-0247OC","article-title":"Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease","volume":"188","author":"Cheng","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2022.04.004_bib33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/prca.200900128","article-title":"Proteomic studies on receptor for advanced glycation end product variants in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease","volume":"4","author":"Ohlmeier","year":"2010","journal-title":"Proteonomics Clin Appl"},{"key":"10.1016\/j.resinv.2022.04.004_bib34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1164\/rccm.200810-1596OC","article-title":"Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis","volume":"180","author":"Konishi","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2022.04.004_bib35","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12931-016-0460-2","article-title":"Increased AGE-RAGE ratio in idiopathic pulmonary fibrosis","volume":"17","author":"Machahua","year":"2016","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2022.04.004_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180092","article-title":"Receptor for advanced glycation endproducts (RAGE) maintains pulmonary structure and regulates the response to cigarette smoke","volume":"12","author":"Wolf","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2022.04.004_bib37","doi-asserted-by":"crossref","first-page":"L1427","DOI":"10.1152\/ajplung.00075.2007","article-title":"The role of the receptor for advanced glycation end-products in lung fibrosis","volume":"293","author":"He","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.resinv.2022.04.004_bib38","doi-asserted-by":"crossref","first-page":"12811","DOI":"10.1038\/s41598-020-69184-8","article-title":"The Gly82Ser mutation in AGER contributes to pathogenesis of pulmonary fibrosis in combined pulmonary fibrosis and emphysema (CPFE) in Japanese patients","volume":"10","author":"Kinjo","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2022.04.004_bib39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12931-020-01410-3","article-title":"Reduced endogenous secretory RAGE in blood and bronchoalveolar lavage fluid is associated with poor prognosis in idiopathic pulmonary fibrosis","volume":"21","author":"Yamaguchi","year":"2020","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2022.04.004_bib40","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1096\/fj.08-109033","article-title":"A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)","volume":"22","author":"Raucci","year":"2008","journal-title":"Faseb J"},{"key":"10.1016\/j.resinv.2022.04.004_bib41","doi-asserted-by":"crossref","first-page":"L516","DOI":"10.1152\/ajplung.00118.2010","article-title":"Proteolytic release of the receptor for advanced glycation end products from in\u00a0vitro and in situ alveolar epithelial cells","volume":"300","author":"Yamakawa","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.resinv.2022.04.004_bib42","doi-asserted-by":"crossref","first-page":"35507","DOI":"10.1074\/jbc.M806948200","article-title":"Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases","volume":"283","author":"Zhang","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2022.04.004_bib43","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.bbadis.2015.02.003","article-title":"Effect of chronic hypoxia on RAGE and its soluble forms in lungs and plasma of mice","volume":"1852","author":"Gopal","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.resinv.2022.04.004_bib44","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1165\/rcmb.2007-0330OC","article-title":"The role of high mobility group box1 in pulmonary fibrosis","volume":"39","author":"Hamada","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.resinv.2022.04.004_bib45","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/resp.13634","article-title":"Serum high-mobility group box 1 is associated with the onset and severity of acute exacerbation of idiopathic pulmonary fibrosis","volume":"25","author":"Yamaguchi","year":"2020","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2022.04.004_bib46","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/resp.13707","article-title":"Clinical significance of serum S100 calcium-binding protein A4 in idiopathic pulmonary fibrosis","volume":"25","author":"Akiyama","year":"2020","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2022.04.004_bib47","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.rmed.2011.12.010","article-title":"S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis","volume":"106","author":"Hara","year":"2012","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2022.04.004_bib48","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10753-010-9210-7","article-title":"Calgranulin B (S100A9\/MRP14): a key molecule in idiopathic pulmonary fibrosis?","volume":"34","author":"Bargagli","year":"2011","journal-title":"Inflammation"},{"key":"10.1016\/j.resinv.2022.04.004_bib49","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2119\/2008-00034.Klune","article-title":"HMGB1: endogenous danger signaling","volume":"14","author":"Klune","year":"2008","journal-title":"Mol Med"},{"key":"10.1016\/j.resinv.2022.04.004_bib50","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cytogfr.2006.01.003","article-title":"High-mobility group box 1 (HMGB1) protein: friend and foe","volume":"17","author":"Ulloa","year":"2006","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.resinv.2022.04.004_bib51","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.2741\/e178","article-title":"Soluble form of a receptor for advanced glycation end products (sRAGE) as a biomarker","volume":"2","author":"Yamagishi","year":"2010","journal-title":"Front Biosci"},{"key":"10.1016\/j.resinv.2022.04.004_bib52","doi-asserted-by":"crossref","first-page":"25752","DOI":"10.1074\/jbc.270.43.25752","article-title":"The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system","volume":"270","author":"Hori","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.resinv.2022.04.004_bib53","article-title":"Toll-like receptor 4 mediates acute lung injury induced by high mobility group box-1","volume":"8","author":"Deng","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2022.04.004_bib54","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11010-013-1680-0","article-title":"The activation of HMGB1 as a progression factor on inflammation response in normal human bronchial epithelial cells through RAGE\/JNK\/NF-kappaB pathway","volume":"380","author":"Wu","year":"2013","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.resinv.2022.04.004_bib55","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1164\/rccm.200402-188OC","article-title":"Contributions of high mobility group box protein in experimental and clinical acute lung injury","volume":"170","author":"Ueno","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2022.04.004_bib56","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1182\/blood-2002-05-1300","article-title":"Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells","volume":"101","author":"Fiuza","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.resinv.2022.04.004_bib57","article-title":"High mobility group box 1 induced human lung myofibroblasts differentiation and enhanced migration by activation of MMP-9","volume":"10","author":"Lee","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2022.04.004_bib58","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.3892\/mmr.2017.6364","article-title":"HMGB1 induces lung fibroblast to myofibroblast differentiation through NF-\u03baB-mediated TGF-\u03b21 release","volume":"15","author":"Wang","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.resinv.2022.04.004_bib59","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1124\/jpet.114.222372","article-title":"High-mobility group box 1 mediates epithelial-to-mesenchymal transition in pulmonary fibrosis involving transforming growth factor-\u03b21\/Smad2\/3 signaling","volume":"354","author":"Li","year":"2015","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.resinv.2022.04.004_bib60","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/labinvest.2015.44","article-title":"High-mobility group box 1 accelerates lipopolysaccharide-induced lung fibroblast proliferation in\u00a0vitro: involvement of the NF-\u03baB signaling pathway","volume":"95","author":"Li","year":"2015","journal-title":"Lab Invest"},{"key":"10.1016\/j.resinv.2022.04.004_bib61","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/10338","article-title":"The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice","volume":"22","author":"Calogero","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.resinv.2022.04.004_bib62","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1465-9921-10-55","article-title":"Blockade of advanced glycation end product formation attenuates bleomycin-induced pulmonary fibrosis in rats","volume":"10","author":"Chen","year":"2009","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2022.04.004_bib63","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.febslet.2009.11.082","article-title":"Advanced glycation end products increase endothelial permeability through the RAGE\/Rho signaling pathway","volume":"584","author":"Hirose","year":"2010","journal-title":"FEBS Lett"},{"key":"10.1016\/j.resinv.2022.04.004_bib64","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.2741\/3315","article-title":"RAGE signaling in inflammation and arterial aging","volume":"14","author":"Lin","year":"2009","journal-title":"Front Biosci"},{"key":"10.1016\/j.resinv.2022.04.004_bib65","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.3389\/fimmu.2018.01776","article-title":"S100A4(+) macrophages are necessary for pulmonary fibrosis by activating lung fibroblasts","volume":"9","author":"Li","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.resinv.2022.04.004_bib66","doi-asserted-by":"crossref","first-page":"105945","DOI":"10.1016\/j.rmed.2020.105945","article-title":"The S100 calcium-binding protein A4 level is elevated in the lungs of patients with idiopathic pulmonary fibrosis","volume":"171","author":"Lee","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2022.04.004_bib67","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2020-000827","article-title":"Serum calprotectin as new biomarker for disease severity in idiopathic pulmonary fibrosis: a cross-sectional study in two independent cohorts","volume":"8","author":"Machahua","year":"2021","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.resinv.2022.04.004_bib68","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1164\/rccm.201101-0058OC","article-title":"Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis","volume":"185","author":"Richards","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2022.04.004_bib69","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000330325","article-title":"Reduction in serum high mobility group box-1 level by polymyxin B-immobilized fiber column in patients with idiopathic pulmonary fibrosis with acute exacerbation","volume":"32","author":"Abe","year":"2011","journal-title":"Blood Purif"},{"key":"10.1016\/j.resinv.2022.04.004_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/916486","article-title":"Gradual increase of high mobility group protein B1 in the lungs after the onset of acute exacerbation of idiopathic pulmonary fibrosis","volume":"2011","author":"Ebina","year":"2011","journal-title":"Pulmonary Medicine"},{"key":"10.1016\/j.resinv.2022.04.004_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196558","article-title":"Association of serum high-mobility group box protein 1 level with outcomes of acute exacerbation of idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia","volume":"13","author":"Shimizu","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2022.04.004_bib72","doi-asserted-by":"crossref","first-page":"9618","DOI":"10.1128\/JVI.01279-16","article-title":"Respiratory Syncytial virus infection triggers epithelial HMGB1 release as a damage-associated molecular pattern promoting a monocytic inflammatory response","volume":"90","author":"Hosakote","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.resinv.2022.04.004_bib73","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/vim.2006.19.3","article-title":"Potential role of high mobility group box 1 in viral infectious diseases","volume":"19","author":"Wang","year":"2006","journal-title":"Viral Immunol"},{"key":"10.1016\/j.resinv.2022.04.004_bib74","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00246-18","article-title":"Serum high-mobility-group box 1 as a biomarker and a therapeutic target during respiratory virus infections","volume":"9","author":"Patel","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.resinv.2022.04.004_bib75","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12931-014-0109-y","article-title":"Autopsy analyses in acute exacerbation of idiopathic pulmonary fibrosis","volume":"15","author":"Oda","year":"2014","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2022.04.004_bib76","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1164\/rccm.201010-1752OC","article-title":"Viral infection in acute exacerbation of idiopathic pulmonary fibrosis","volume":"183","author":"Wootton","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2022.04.004_bib77","doi-asserted-by":"crossref","first-page":"152668","DOI":"10.1016\/j.tox.2020.152668","article-title":"Ozone exposure promotes pyroptosis in rat lungs via the TLR2\/4-NF-\u03baB-NLRP3 signaling pathway","volume":"450","author":"Tian","year":"2021","journal-title":"Toxicology"},{"key":"10.1016\/j.resinv.2022.04.004_bib78","first-page":"33","article-title":"Inflammasome, IL-1 and inflammation in ozone-induced lung injury","volume":"5","author":"Michaudel","year":"2016","journal-title":"Am J Clin Exp Immunol"},{"key":"10.1016\/j.resinv.2022.04.004_bib79","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.resp.2011.03.023","article-title":"Long-term exposure to cigarette smoke impairs lung function and increases HMGB-1 expression in mice","volume":"177","author":"Bezerra","year":"2011","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.resinv.2022.04.004_bib80","doi-asserted-by":"crossref","first-page":"L473","DOI":"10.1152\/ajplung.00287.2017","article-title":"Roles of high-mobility group box 1 and thrombin in murine pulmonary fibrosis and the therapeutic potential of thrombomodulin","volume":"314","author":"Kida","year":"2018","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.resinv.2022.04.004_bib81","doi-asserted-by":"crossref","first-page":"10105","DOI":"10.1038\/s41598-021-89663-w","article-title":"Predictive role of circulatory HMGB1 in postoperative acute exacerbation of interstitial lung disease in lung cancer patients","volume":"11","author":"Yamaguchi","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2022.04.004_bib82","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.resinv.2021.05.008","article-title":"Serum S100A8 and S100A9 as prognostic biomarkers in acute exacerbation of idiopathic pulmonary fibrosis","volume":"59","author":"Tanaka","year":"2021","journal-title":"Respir Investig"},{"key":"10.1016\/j.resinv.2022.04.004_bib83","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12890-021-01554-y","article-title":"Serum S100 calcium-binding protein A4 as a novel predictive marker of acute exacerbation of interstitial pneumonia after surgery for lung cancer","volume":"21","author":"Kagimoto","year":"2021","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.resinv.2022.04.004_bib84","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.rmed.2009.05.019","article-title":"Serum high mobility group box protein 1 as a clinical marker for non-small cell lung cancer","volume":"103","author":"Shang","year":"2009","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2022.04.004_bib85","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1248\/bpb.b19-00702","article-title":"Docetaxel upregulates HMGB1 levels in non-small cell lung cancer","volume":"43","author":"Haruna","year":"2020","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.resinv.2022.04.004_bib86","doi-asserted-by":"crossref","first-page":"L958","DOI":"10.1152\/ajplung.00359.2004","article-title":"HMGB1 contributes to the development of acute lung injury after hemorrhage","volume":"288","author":"Kim","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.resinv.2022.04.004_bib87","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1164\/rccm.200605-699OC","article-title":"Contribution of high-mobility group box-1 to the development of ventilator-induced lung injury","volume":"174","author":"Ogawa","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2022.04.004_bib88","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/SHK.0b013e318157eddd","article-title":"Pulmonary levels of high-mobility group box 1 during mechanical ventilation and ventilator-associated pneumonia","volume":"29","author":"van Zoelen","year":"2008","journal-title":"Shock"},{"key":"10.1016\/j.resinv.2022.04.004_bib89","doi-asserted-by":"crossref","first-page":"6714","DOI":"10.1002\/jcp.26341","article-title":"HMGB1 contributes to the irradiation-induced endothelial barrier injury through receptor for advanced glycation endproducts (RAGE)","volume":"233","author":"Zhou","year":"2018","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.resinv.2022.04.004_bib90","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4149\/neo_2010_01_055","article-title":"Receptor for advanced glycation end products (RAGE) soluble form (sRAGE): a new biomarker for lung cancer","volume":"57","author":"Jing","year":"2010","journal-title":"Neoplasma"},{"key":"10.1016\/j.resinv.2022.04.004_bib91","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/resp.12960","article-title":"Nintedanib in Japanese patients with idiopathic pulmonary fibrosis: a subgroup analysis of the INPULSIS(R) randomized trials","volume":"22","author":"Azuma","year":"2017","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2022.04.004_bib92","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/JTO.0b013e318216ee6b","article-title":"The risk of cytotoxic chemotherapy-related exacerbation of interstitial lung disease with lung cancer","volume":"6","author":"Kenmotsu","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.resinv.2022.04.004_bib93","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.jtcvs.2013.09.050","article-title":"Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer","volume":"147","author":"Sato","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.resinv.2022.04.004_bib94","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.resp.2008.10.017","article-title":"Controversial role of RAGE in the pathogenesis of idiopathic pulmonary fibrosis","volume":"165","author":"Bargagli","year":"2009","journal-title":"Respir Physiol Neurobiol"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221253452200048X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221253452200048X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:33:20Z","timestamp":1761950000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221253452200048X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":94,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S221253452200048X"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2022.04.004","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of the RAGE\/RAGE-ligand axis with interstitial lung disease and its acute exacerbation","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2022.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}